Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate (Q39060404)

8 September 2017

title

Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate (English)

1 reference

8 September 2017

1 reference

6

Marina Simian

1 reference

8 September 2017

Diego Raffo

1

1 reference

8 September 2017

Damian E Berardi

2

1 reference

8 September 2017

Osvaldo Pontiggia

3

1 reference

8 September 2017

Laura Todaro

4

1 reference

8 September 2017

Elisa Bal de Kier Joffé

5

1 reference

8 September 2017

language of work or name

English

0 references

publication date

21 November 2013

1 reference

Breast Cancer Research and Treatment

8 September 2017

published in

1 reference

8 September 2017

volume

142

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

537-548

1 reference

Mechanisms of endocrine resistance in breast cancer

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Targeted therapies of metastatic breast cancer: relationships with cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Effects of estrogen on the proportion of stem cells in the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2760-2

10.1007/S10549-013-2760-2

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference